Trevi Therapeutics Inc. trailing returns
How Trevi Therapeutics Inc. (TRVI) has performed over the last day, week, month and year, over 5 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.
Trailing returns by period#
To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.
| Period | Price | DivsDividends | Total | Worst drop |
|---|---|---|---|---|
| 1 day | +7.8% | +0.0% | +7.8% | — |
| 5 days | +4.4% | +0.0% | +4.4% | -3.3%Oct 16 |
| 1 month | -14.2% | +0.0% | -14.2% | -22.0%Oct 16 |
| YTD | +2.5% | +0.0% | +2.5% | -39.1%Oct 16 |
| 1 year | +20.0% | +0.0% | +20.0% | -39.1%Oct 2026 |
| 5 years | +58.8% | +0.0% | +58.8%+910.2% | -75.1%Nov 2023 |
| Since inception (2019) | +6.7% | +0.0% | +6.7%+62.6% | -95.5%Feb 2022 |
Growth of TRVI#
Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.
- 5 years+58.8%/year · +910.2%
Methodology#
Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in TRVI's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.
FAQ#
- What is Trevi Therapeutics Inc.'s return since inception?
- Since 2019, Trevi Therapeutics Inc. (TRVI) has compounded at about +6.7% a year — +62.6% in total.